Torrent Pharma shares gain on USFDAs VAI tag to Pithampur facility - Business Standard
TORNTPHARM | 3,324 121.25 3.79% |
Under 55% of Torrent Pharmaceuticals' traders are presently thinking to get in. The analysis of overall sentiment of trading Torrent Pharmaceuticals Limited stock suggests that some investors are interested at this time. Torrent Pharmaceuticals' investing sentiment shows overall attitude of investors towards Torrent Pharmaceuticals Limited.
Torrent |
Torrent Pharma shares gain on USFDAs VAI tag to Pithampur facility Business Standard
Read at news.google.com
Torrent Pharmaceuticals Fundamental Analysis
We analyze Torrent Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Torrent Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Torrent Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Torrent Pharmaceuticals is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Torrent Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Torrent Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Torrent Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Torrent Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Torrent Pharmaceuticals Related Equities
LTFOODS | LT Foods | 1.48 | ||||
PARAGMILK | Parag Milk | 1.10 | ||||
ABAN | Aban Offshore | 0.95 | ||||
BECTORFOOD | Mrs Bectors | 0.90 | ||||
SALZERELEC | Salzer Electronics | 0.13 | ||||
MELSTAR | Melstar Information | 0.00 | ||||
VINATIORGA | Vinati Organics | 0.18 | ||||
HATHWAY | Hathway Cable | 0.80 |
Complementary Tools for Torrent Stock analysis
When running Torrent Pharmaceuticals' price analysis, check to measure Torrent Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Torrent Pharmaceuticals is operating at the current time. Most of Torrent Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Torrent Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Torrent Pharmaceuticals' price. Additionally, you may evaluate how the addition of Torrent Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |